Abvc Biopharma (ABVC) Other Non-Current Liabilities (2019 - 2026)
Abvc Biopharma (ABVC) recorded Other Non-Current Liabilities of $31,167 in Q2 2026, down 25.2% from $41,680 a year earlier.
Powered by 
Analysis
Abvc Biopharma (ABVC) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2024, Abvc Biopharma reported Other Non-Current Liabilities of $21,680, unchanged from FY2023.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of 49.7% (FY2019 to FY2024).
- Across earlier years, Other Non-Current Liabilities came in at $21,680 in FY2023 (+171.7%), $7,980 in FY2022 (-24.6%), $10,580 in FY2021 (-45.1%) and $19,280 in FY2020 (+569.4%).
- The Q2 2026 figure is the lowest quarterly Other Non-Current Liabilities since Q1 2025.
- On a year-over-year basis, Other Non-Current Liabilities rose in three of the last six quarters, with growth averaging 69.2%.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 387.3% in Q2 2024, against a decline of 55.9% in Q3 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31,167.00 |
| Sep 30, 2025 | 35,404.00 |
| Jun 30, 2025 | 41,680.00 |
| Mar 31, 2025 | 21,680.00 |
| Dec 31, 2024 | 21,680.00 |
| Sep 30, 2024 | 25,680.00 |
| Jun 30, 2024 | 27,680.00 |
| Mar 31, 2024 | 21,680.00 |
| Dec 31, 2023 | 21,680.00 |
| Sep 30, 2023 | 5,680.00 |
| Jun 30, 2023 | 5,680.00 |
| Mar 31, 2023 | 7,480.00 |
| Dec 31, 2022 | 7,980.00 |
| Sep 30, 2022 | 12,880.00 |
| Jun 30, 2022 | 11,980.00 |
| Mar 31, 2022 | 7,980.00 |
| Dec 31, 2021 | 10,580.00 |
| Sep 30, 2021 | 9,880.00 |
| Jun 30, 2021 | 17,180.00 |
| Mar 31, 2021 | 11,080.00 |
API Access
Abvc Biopharma Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();